{
  "id": 1100,
  "name": "Perlara",
  "slug": "perlara",
  "former_names": [
    "Perlstein Lab PBC"
  ],
  "small_logo_thumb_url": "/company/thumb/missing.png",
  "website": "http://perlara.com",
  "all_locations": "Oakland, CA, USA; Remote",
  "long_description": "Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos.\r\n\r\nPerlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively.\r\n\r\nPerlara 2.0 (May 2020 --> The first decentralized and distributed biotech\r\n",
  "one_liner": "Perlara: building the YC for rare disease parents",
  "team_size": 1,
  "industry": "Healthcare",
  "subindustry": "Healthcare -> Drug Discovery and Delivery",
  "launched_at": 1451985616,
  "tags": [],
  "tags_highlighted": [],
  "top_company": false,
  "isHiring": false,
  "nonprofit": false,
  "batch": "W16",
  "status": "Active",
  "industries": [
    "Healthcare",
    "Drug Discovery and Delivery"
  ],
  "regions": [
    "United States of America",
    "America / Canada",
    "Remote",
    "Fully Remote"
  ],
  "stage": "Early",
  "app_video_public": false,
  "demo_day_video_public": true,
  "app_answers": null,
  "question_answers": false,
  "url": "https://www.ycombinator.com/companies/perlara",
  "api": "https://yc-oss.github.io/api/batches/w16/perlara.json"
}
